## Mechanistic Overview
The hypothesis centers on SLCO2A1 (encoded by the solute carrier organic anion transporter family member 2A1, also known as OATP2A1 or prostaglandin transporter), a membrane transporter protein expressed at the blood-brain barrier (BBB) that mediates the cellular uptake of prostaglandins and related eicosanoids. Under normal physiological conditions, OATP2A1 facilitates prostaglandin clearance from the brain parenchyma into circulation, functioning as part of a coordinat
# Therapeutic Hypotheses: Metabolomic Signatures of Neurodegeneration
---
## Hypothesis 1: Restoration of Neuronal Ketone Body Utilization via MCT1 Upregulation
**Title:** MCT1 transporter upregu...
Skeptic
# Critical Evaluation of Metabolomic Hypotheses for Neurodegeneration
I'll provide a rigorous scientific critique of each hypothesis, identifying weaknesses, counter-evidence, alternative explanati...
Domain Expert
# Drug Discovery Assessment: Metabolomic Hypotheses for Neurodegeneration
## Executive Summary
All seven hypotheses face significant translational barriers. The metabolomics field provides genuine...
NAD+ Precursor Supplementation to Reverse Poly(ADP
4 rounds · quality: 0.50
Theorist
# Therapeutic Hypotheses: Metabolomic Signatures of Neurodegeneration
---
## Hypothesis 1: Restoration of Neuronal Ketone Body Utilization via MCT1 Upregulation
**Title:** MCT1 transporter upregu...
Skeptic
# Critical Evaluation of Metabolomic Hypotheses for Neurodegeneration
I'll provide a rigorous scientific critique of each hypothesis, identifying weaknesses, counter-evidence, alternative explanati...
Domain Expert
# Drug Discovery Assessment: Metabolomic Hypotheses for Neurodegeneration
## Executive Summary
All seven hypotheses face significant translational barriers. The metabolomics field provides genuine...